Prasad Uno Family Trust acquires 2.5% stake in Entero Healthcare via block deal

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Prasad Uno Family Trust acquired 10,88,500 shares (2.50%) via block deal on August 24, 2026
  • Voting stake rose from 4.31% to 6.93% of total share capital
  • Encumbered shares dropped sharply from 6.13% to 1.01% of total capital
  • Filing made under SEBI SAST Regulations Regulation 29(2) on August 26, 2026
powered bylight_fuzz_icon
49293229

*this image is generated using AI for illustrative purposes only.

Prasad Uno Family Trust acquired 10,88,500 equity shares of Entero Healthcare Solutions Ltd through a block deal on August 24, 2026. The transaction represents a 2.50% stake in the company’s total share capital.

The disclosure was filed with the Bombay Stock Exchange and the National Stock Exchange on August 26, 2026, under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Surbhi Singh, trustee of the trust, signed the filing.

Stake Movement Details

The acquisition increased the trust’s voting rights from 4.31% to 6.93% of the total share capital. In terms of diluted voting capital, the stake rose from 4.29% to 6.90%.

Metric Before Acquisition After Acquisition Change
Shares carrying voting rights 18,74,770 (4.31%) 30,14,920 (6.93%) +10,88,500 shares
Diluted voting rights 4.29% 6.90% +2.49%
Total diluted capital 4,37,18,962 shares 4,37,18,962 shares No change

The company’s total equity share capital remained unchanged at INR 43,52,30,720, comprising 4,35,23,072 equity shares of face value INR 10 each. The total diluted share capital includes 1,95,890 shares underlying outstanding ESOPs.

Encumbrance Reduction

A notable shift occurred in the pledge status of the holdings. Before the transaction, the trust held 26,69,150 shares (6.13%) under encumbrance. Post-acquisition, the encumbered portion dropped to 4,40,500 shares (1.01%).

This reduction suggests a significant release of pledged shares or that the newly acquired shares were unencumbered, altering the risk profile of the trust’s overall position. The total holding including encumbrances stands at 34,55,420 shares (7.94% of total share capital).

What the Numbers Show

The divergence between the increase in free voting rights and the sharp decline in encumbered shares indicates a restructuring of the trust’s collateral base. While the economic exposure increased by 2.50%, the secured portion of the portfolio contracted by over 5 percentage points, potentially freeing up liquidity or reducing margin call risks for the acquirer.

Historical Stock Returns for Entero Healthcare Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+3.14%+28.42%+42.03%+75.25%+49.42%0.0%

What strategic rationale might drive the Prasad Uno Family Trust to increase its voting stake while simultaneously reducing pledged shares?

How could this reduction in encumbered shares impact Entero Healthcare Solutions' credit rating or borrowing capacity?

Will the increased institutional confidence from this block deal influence short-term trading volume and price volatility for Entero Healthcare shares?

Entero Healthcare Solutions
View Company Insights
View All News
like16
dislike

Entero Healthcare Solutions hosts investor conference on Sep 2

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Entero Healthcare Solutions holds investor conference on September 2, 2026
  • Event organized by Elara Capital in physical mode at Mumbai
  • Officials to engage in 1x1 and group meetings starting 3:00 pm
  • Discussions limited to publicly available information only
powered bylight_fuzz_icon
49130010

*this image is generated using AI for illustrative purposes only.

Entero Healthcare Solutions Limited will host an investor conference on September 2, 2026, at 3:00 pm in Mumbai. The company disclosed the schedule under SEBI Listing Obligations and Disclosure Requirements Regulations 2015.

The interaction is organized by Elara Capital and will take place in a physical format. Company officials will participate in both one-on-one and group meetings with analysts and institutional investors.

Event Details

Date Time Type of Interaction Organized by Mode Location
September 2, 2026 3:00 pm onwards 1x1 / Group Meeting Elara Capital Physical Mumbai

Discussions during the conference will be based strictly on publicly available information. The company stated that no unpublished price-sensitive information (UPSI) is intended to be discussed.

Sanu Kapoor, Vice President- Group General Counsel, Company Secretary & Compliance Officer, signed the intimation letter dated August 24, 2026. The company noted that changes to the schedule may occur due to exigencies on the part of participants or the company.

Historical Stock Returns for Entero Healthcare Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+3.14%+28.42%+42.03%+75.25%+49.42%0.0%

How might Entero Healthcare's upcoming strategic updates at the conference influence its stock valuation in the short term?

What specific growth metrics or expansion plans are analysts likely to probe during the one-on-one sessions with institutional investors?

Could the physical format of the meeting in Mumbai signal a shift in the company's investor relations strategy compared to previous virtual engagements?

Entero Healthcare Solutions
View Company Insights
View All News
like16
dislike

More News on Entero Healthcare Solutions

1 Year Returns:+49.42%